Measuring patient perceptions about osteoporosis pharmacotherapy
<p>Abstract</p> <p>Background</p> <p>Adherence to osteoporosis pharmacotherapy is poor, and linked with patient perceptions of the benefits of, and barriers to taking these treatments. To better understand the association between patient perceptions and osteoporosis pha...
Main Authors: | Jaglal Susan B, Gignac Monique AM, Cadarette Suzanne M, Beaton Dorcas E, Hawker Gillian A |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-07-01
|
Series: | BMC Research Notes |
Online Access: | http://www.biomedcentral.com/1756-0500/2/133 |
Similar Items
-
Methodological guidance for the use of real-world data to measure exposure and utilization patterns of osteoporosis medications
by: Kaleen N. Hayes, et al.
Published: (2024-03-01) -
Social implication, economic aspects and new abilities of strontium ranelate in pharmacotherapy for postmenopausal osteoporosis
by: I S Dydykina, et al.
Published: (2008-09-01) -
Change of genitourinary cancer patients' perception and expectations over the course of pharmacotherapy.
by: Yoshiaki Satou, et al.
Published: (2022-01-01) -
Change of genitourinary cancer patients’ perception and expectations over the course of pharmacotherapy
by: Yoshiaki Satou, et al.
Published: (2022-01-01) -
Pharmacotherapy for Alcohol Use Disorders: Physicians’ Perceptions and Practices
by: Caridad Ponce Martinez, et al.
Published: (2016-11-01)